CA1339958C - Isoferritine, marqueur pour grossesse pathologique - Google Patents
Isoferritine, marqueur pour grossesse pathologiqueInfo
- Publication number
- CA1339958C CA1339958C CA000595762A CA595762A CA1339958C CA 1339958 C CA1339958 C CA 1339958C CA 000595762 A CA000595762 A CA 000595762A CA 595762 A CA595762 A CA 595762A CA 1339958 C CA1339958 C CA 1339958C
- Authority
- CA
- Canada
- Prior art keywords
- plf
- antibody
- pregnancy
- molecule
- ferritin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Transplantation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17918388A | 1988-04-08 | 1988-04-08 | |
US07/179,183 | 1988-04-08 | ||
US07/210,601 | 1988-06-23 | ||
US07/210,601 US4954434A (en) | 1981-05-15 | 1988-06-23 | Isoferritin as a marker for pathological pregnancy |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1339958C true CA1339958C (fr) | 1998-07-21 |
Family
ID=26875089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000595762A Expired - Fee Related CA1339958C (fr) | 1988-04-08 | 1989-04-05 | Isoferritine, marqueur pour grossesse pathologique |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0408651A4 (fr) |
JP (1) | JPH03504640A (fr) |
CA (1) | CA1339958C (fr) |
WO (1) | WO1989009936A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107106588A (zh) * | 2014-10-28 | 2017-08-29 | 山口晃史 | 用于改善妊娠状态的药剂及其使用 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL126181A0 (en) * | 1998-09-11 | 1999-05-09 | Univ Ramot | Dna sequences proteins coded by them medicaments and detection methods using same |
US7217686B1 (en) | 1999-09-08 | 2007-05-15 | Gardino Investment N.V. | DNA sequence encoding oncofetal ferritin protein |
US11541040B2 (en) | 2014-10-28 | 2023-01-03 | Kouchi Yamaguchi | Medicine for improving state of pregnancy, and use thereof |
CN114047336A (zh) * | 2021-12-13 | 2022-02-15 | 大连医科大学 | 一种用于辅助诊断复发性流产的生物标志物及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2748657C3 (de) * | 1977-10-29 | 1980-08-07 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Bestimmung von Ferritin |
IL62879A (en) * | 1981-05-15 | 1985-09-29 | Chaya Moroz | Monoclonal antibodies,clones producing them,preparation of such antibodies and clones and cytotoxic and immunoassay using such antibodies |
US4531046A (en) * | 1983-01-10 | 1985-07-23 | Bunn-O-Matic Corporation | Beverage brewing apparatus with constant temperature water reservoir |
ATE153765T1 (de) * | 1988-03-07 | 1997-06-15 | S Leslie Misrock | Plazentale isoferritine zur prognose und diagnose zur immunosuppression |
-
1989
- 1989-04-05 CA CA000595762A patent/CA1339958C/fr not_active Expired - Fee Related
- 1989-04-07 EP EP19890904973 patent/EP0408651A4/en not_active Withdrawn
- 1989-04-07 WO PCT/US1989/001449 patent/WO1989009936A1/fr not_active Application Discontinuation
- 1989-04-07 JP JP1504769A patent/JPH03504640A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107106588A (zh) * | 2014-10-28 | 2017-08-29 | 山口晃史 | 用于改善妊娠状态的药剂及其使用 |
Also Published As
Publication number | Publication date |
---|---|
JPH03504640A (ja) | 1991-10-09 |
EP0408651A1 (fr) | 1991-01-23 |
EP0408651A4 (en) | 1991-12-27 |
WO1989009936A1 (fr) | 1989-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0447424B1 (fr) | Procede servant a isoler des cellules fetales du sang maternel en vue d'un diagnostic prenatal | |
US4954434A (en) | Isoferritin as a marker for pathological pregnancy | |
TAYLOR et al. | Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block | |
EP0563165A4 (en) | Reagents and kits for determination of fetal restricted antigens | |
EP0674661B1 (fr) | Titrage et traitement destines aux maladies demyelinisantes telles que la sclerose en plaques | |
US4746539A (en) | Purification of cancer-associated protein and preparation of antibody thereto | |
Vyas et al. | Lmmunobiology of human anti‐lgA: a serologic and immunogenetic study of immunization to IgA in transfusion and pregnancy | |
CA1339958C (fr) | Isoferritine, marqueur pour grossesse pathologique | |
CA2093521C (fr) | Detection de toxines diarrheogenes provenant des mollusques | |
Tedesco et al. | Prevalence and biological effects of anti‐trophoblast and anti‐endothelial cell antibodies in patients with recurrent spontaneous abortions | |
JPS63500797A (ja) | 崩壊加速因子に対するモノクロ−ン抗体、その生成方法および使用 | |
EP0145373B1 (fr) | Purification d'une protéine associée au cancer et préparation d'anticorps contre cette protéine | |
RU2210074C2 (ru) | Иммунологический анализ человеческого медуллазина и диагностика рассеянного склероза с его помощью | |
Kaufman et al. | Immune complexes in the portal and systemic circulation of patients with alcoholic liver disease | |
US4743538A (en) | Test for rheumatic fever and monoclonal antibodies useful therefor | |
AU621694B2 (en) | Isolation of fetal cells from maternal blood to enable prenatal diagnosis | |
JP2580028B2 (ja) | 抗ひと精子抗体、その製法および用途 | |
JPH0823969A (ja) | ブルーム症候群患者由来のbリンパ細胞株から誘導された流産関連胎児抗原性を有する細胞クローンならびにそれらの細胞膜蛋白を用いた妊娠早期流産患者血清中流産関連胎児抗体測定による診断法ならびに流産治療薬 | |
JPH03504272A (ja) | 免疫抑制の予知および診断のための胎盤イソフェリチン | |
JPH0975089A (ja) | 流産関連胎児性抗原遺伝子、その抗原決定基を含む合成ペプチドおよびその製造方法並びに用途 | |
JPH06225787A (ja) | 下痢性貝毒特異的モノクローナル抗体、ハイブリドーマ及び下痢性貝毒検出方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed | ||
MKLA | Lapsed |
Effective date: 20010723 |